Keywords
Elderly
Deprescription
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the frequency of medication use in the elderly, with a view to identifying the possible cascade effect of therapeutic drugs in this population and their adverse reactions. Bibliographic Review: In Brazil, it is estimated that around 80% of elderly people use at least one type of medication. Furthermore, the use of more than one therapeutic drug is often observed, and often indiscriminately. Diseases such as high blood pressure, diabetes and adverse disorders emerge as the most prevalent pathological conditions and are motivated by polypharmacy in the elderly, in which the class of antihypertensives, followed by oral hypoglycemic agents and antiplatelet agents, were the drugs with the greatest presence in everyday life. of the elderly population. From this perspective of polypharmacy, or with the use of potentially harmful medications, deprescription appears as a process of withdrawing an inappropriate medication, supervised by a health professional, with the aim of reducing adverse drug effects and improving patients' therapeutic results. Final considerations: Therefore, as more than 90% of elderly patients are receptive to discontinuing unnecessary medications when recommended by healthcare professionals, deprescribing in a primary care context may become easier for clinicians involved with patients and families.
References
ALHARTHI M. et al. Barriers and enablers to deprescribing for older people in care homes: the theory-based perspectives of pharmacist independent prescribers. Res Social Adm Pharm. 2023; 19(5): 746-52.
AUBERT CE, et al. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study. CMAJ Open. 2023; 11(1): e170-e178.
BAYLISS EA, et al. Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians: the optimize pragmatic cluster randomized trial. JAMA Intern Med. 2022; 182(5): 534-542.
CATEAU D, et al. Effects of an interprofessional quality circle-deprescribing modulo (QC-DeMo) in swiss nursing homes: a randomised controlled trial. BMC Geriatr. 2021; 21(289): s12877.
COSTA JVG, et al. Perfil do uso de medicamentos por idosos: sob o olhar farmacêutico. Revista Multidiscplinar e de psicologia. 2020; 14(52): 9.
FOURNIER A, et al. Use and Deprescribing of Potentially Inappropriate Medications in Frail Nursing Home Residents. Drugs Aging. 2020; 37(12): 917-924.
GARCÍA, P. et al. Deprescription in old people: It's time to take action. Aten Primaria. 2022; 54(8): 102367.
JAMIESON H, et al. Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: A Randomized Controlled Trial. J Gerontol A Biol Sci Med Sci. 2023; 78(9): 1692-1700.
LUYMES CH, et al. Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial. BMC Med. 2018; 16(1): 5.
MAUÉS CR, et al. Análise do uso de medicamentos em idosos. Revista Eletrônica Acervo Saúde. 2019; 1(34): e1356.
MORTSIEFER A, et al. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial. JAMA Netw Open. 2023; 6(3): e234723.
OKTORA MP, et al. Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study. BMC Geriatr. 2023; 23(1): s12877.
OLIVEIRA LMZ, PINTO, RR. A utilização da polifarmácia entre idosos e seus riscos. Brazilian Journal of Development. 2021; 7(11): 9.
ONDER G, et al. Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors. J Am Med Dir Assoc. 2019; 20(9): 1116-1120.
SANZ-TAMARGO G, et al. Adaptation of a deprescription intervention to the medication management of older people living in long-term care facilities. Experto Opin Drug Saf. 2018; 18(11): 1091-1098.
SHEPPARD JP, et al. Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 yers and older: the optimise randomized clinical trial. JAMA. 2020; 323(20): 2039-2051.
SILVA KD, FREITAS GR. Desprescrição em idosos: uma revisão da literatura. Diversitates Int J. 2019; 11(1).
STEFANO ICA, et al. Uso de medicamentos por idosos: análise da prescrição, dispensação e utilização num município de porte médio do estado de São Paulo. Rev. Bras. Geriatr. Gerontol. 2017; 20(5): 12.
VIANA SSC, et al. Use of potentially inappropriate medications and adverse events in older outpatients with acute conditios. Einstein. 2022; 20: AO8024.
WONG APY, et al. Feasibility & Efficacy of Deprescribing rounds in a Singapore rehabilitative hospital- a randomised controlled trial. BMC Geriatr. 2021; 21(1): 584.
ZECHMANN S, et al. Effect of a patient-centred deprescribing procedure in older multimorbid patients in swiss primary care: a cluster-randomised clinical trial. BMC Geratr. 2020; 20(1): s12877.